We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+9.91%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$220M
AUM Growth
-$31.3M
Cap. Flow
-$47.9M
Cap. Flow %
-21.81%
Top 10 Hldgs %
16.28%
Holding
158
New
Increased
Reduced
96
Closed
8

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Healthcare 17.7%
3 Consumer Discretionary 12.43%
4 Communication Services 10.83%
5 Financials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
126
Omnicell
OMCL
$1.86B
$922K 0.42%
21,403
-8,200
-28% -$341K
MMSI icon
127
Merit Medical Systems
MMSI
$4.43B
$908K 0.41%
23,810
-9,121
-28% -$305K
URBN icon
128
Urban Outfitters
URBN
$5.99B
$907K 0.41%
48,914
AR icon
129
Antero Resources
AR
$10.9B
$881K 0.4%
40,746
GNTX icon
130
Gentex
GNTX
$4.88B
$880K 0.4%
46,375
KMI icon
131
Kinder Morgan
KMI
$73.1B
$878K 0.4%
45,800
PDFS icon
132
PDF Solutions
PDFS
$2.13B
$874K 0.4%
53,150
-20,362
-28% -$378K
SJM icon
133
J.M. Smucker
SJM
$12.6B
$870K 0.4%
7,352
BRK.B icon
134
Berkshire Hathaway Class B
BRK.B
$1.07T
$861K 0.39%
5,086
HII icon
135
Huntington Ingalls Industries
HII
$11.3B
$846K 0.39%
4,543
VEEV icon
136
Veeva Systems
VEEV
$30.3B
$843K 0.38%
13,756
-5,270
-28% -$304K
HSTM icon
137
HealthStream
HSTM
$793M
$834K 0.38%
31,678
-12,136
-28% -$333K
NRC icon
138
NRC Health Common Stock
NRC
$474M
$808K 0.37%
30,025
-11,502
-28% -$281K
NXTM
139
DELISTED
NxStage Medical Inc.
NXTM
$806K 0.37%
32,168
-12,323
-28% -$305K
AKAM icon
140
Akamai
AKAM
$16.8B
$797K 0.36%
15,994
WBA
141
DELISTED
Walgreens Boots Alliance
WBA
$734K 0.33%
9,373
DPLO
142
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$724K 0.33%
48,938
-18,748
-28% -$312K
MHK icon
143
Mohawk Industries
MHK
$6.9B
$713K 0.32%
2,950
CLR
144
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$696K 0.32%
21,539
ACRS icon
145
Aclaris Therapeutics
ACRS
$730M
$678K 0.31%
24,986
-9,572
-28% -$260K
ORLY icon
146
O'Reilly Automotive
ORLY
$72.4B
$667K 0.3%
45,720
NTRA icon
147
Natera
NTRA
$37.5B
$654K 0.3%
60,212
-23,067
-28% -$225K
TXMD icon
148
TherapeuticsMD
TXMD
$23.8M
$600K 0.27%
2,276
-872
-28% -$218K
PRMW
149
DELISTED
Primo Water Corporation
PRMW
$570K 0.26%
44,865
-17,187
-28% -$214K
KNSL icon
150
Kinsale Capital Group
KNSL
$7.95B
$526K 0.24%
14,107
-5,405
-28% -$190K

Similar funds

Capital Impact Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Capital Impact Advisors held 158 positions worth $220M, down 12% from $251M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Capital Impact Advisors withdrew a net $47.9M in Q2 2017, closing 8 positions and reducing 96 holdings. Its most notable exit was GCI Liberty, Inc. Class A-1 Common Stock, an estimated $1.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Impact Advisors's biggest Q2 2017 reduction was EPAM Systems, cutting an estimated $655K.
  • Capital Impact Advisors fully exited GCI Liberty, Inc. Class A-1 Common Stock in Q2 2017, selling an estimated $1.64M.
  • Capital Impact Advisors's ten largest holdings make up 16% of its $220M portfolio in Q2 2017.
  • Capital Impact Advisors opened 0 new positions and closed 8 in Q2 2017.
  • Capital Impact Advisors's portfolio value fell 12% quarter-over-quarter to $220M.

Based on Capital Impact Advisors's 13F filing for Q2 2017, filed 18 Jul 2017.